Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3842546 | 0.73 | GSK3A (0.32) | GSK3AGSK3B | |
| SCHEMBL1977276 | 0.58 | — | — | |
| SCHEMBL20627543 | 0.58 | GSK3A (0.31) | GSK3AGSK3B | |
| SCHEMBL16360937 | 0.58 | — | — | |
| SCHEMBL12128929 | 0.58 | — | — | |
| SCHEMBL9205303 | 0.58 | — | — | |
| SCHEMBL3036797 | 0.56 | — | — | |
| SCHEMBL8608379 | 0.56 | MAOA (0.33) | — | |
| SCHEMBL21671035 | 0.56 | P2RX7 (0.30) | — | |
| SCHEMBL5157832 | 0.55 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119816300-A | Composition and method for producing the same | 埃斯特雷努埃私人有限公司 | 2025-04-11 | — | — | CN | disclosed |
| CN-118772223-A | Compositions and methods for treating central nervous system disorders | 萨奇治疗股份有限公司 | 2024-10-15 | — | — | CN | disclosed |
| CN-111741965-B | Compositions and methods for treating central nervous system disorders | 萨奇治疗股份有限公司 | 2024-06-25 | — | — | CN | disclosed |
| CN-118206604-A | Synthesis method of monovalent gold catalyzed 1, 3-diene-1-carbonyl derivative | 沈阳药科大学 | 2024-06-18 | — | — | CN | disclosed |
| EP-1501835-A2 | 2-(QUINOLONYL)-FUSED HETEROCYCLES AS ANDROGEN RECEPTOR MODULATORS | Ortho-Mcneil Pharmaceutical, Inc. (US) | 2005-02-02 | — | — | EP | disclosed |
| WO-2003090672-A2 | 2-(QUINOLONYL)-FUSED HETEROCYCLES AS ANDROGEN RECEPTOR MODULATORS | ORTHO-MCNEIL PHARMACEUTICAL, INC. (US) | 2003-11-06 | — | — | WO | disclosed |